SW
AMPH icon

SteelPeak Wealth’s Amphastar Pharmaceuticals AMPH Stock Holding History

SteelPeak Wealth’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$982K Buy
48,684
+222
+0.5% +$4.48K 0.03% 312
2026
Q1 		$949K Sell
48,462
-7,233
-13% -$177K 0.03% 292
2025
Q4 		$1.49M Hold
55,695
– – 0.05% 243
2025
Q3 		$1.48M Sell
55,695
-100
-0.2% -$2.58K 0.05% 246
2025
Q2 		$1.28M Hold
55,795
– – 0.05% 241
2025
Q1 		$1.62M Buy
+55,795
New +$1.78M 0.07% 201

Other funds holding AMPH

LG
LAM Group Lake Oswego, Oregon $201M AUM 22.35% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SWP
Significant Wealth Partners Cary, Illinois $92.4M AUM 9.22% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.46B AUM 21.89% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
1IA
1620 Investment Advisors Plymouth, Massachusetts $161M AUM 30.15% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

SteelPeak Wealth's AMPH Position: Q2 2026 in Review

SteelPeak Wealth increased its Amphastar Pharmaceuticals (AMPH) stake by 0.46% in Q2 2026, buying an estimated $4.48K and bringing the position to 48,684 shares worth $982K. The position accounts for 0.03% of the portfolio, ranked #312.

SteelPeak Wealth first reported a position in AMPH in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.62M in Q1 2025. 20 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • SteelPeak Wealth held 48,684 shares of Amphastar Pharmaceuticals worth $982K as of Q2 2026.
  • SteelPeak Wealth bought 222 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $4.48K.
  • Amphastar Pharmaceuticals made up 0.03% of SteelPeak Wealth's portfolio in Q2 2026, its #312 holding.
  • SteelPeak Wealth first reported a position in Amphastar Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • SteelPeak Wealth's Amphastar Pharmaceuticals position peaked at $1.62M in Q1 2025.
  • 20 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on SteelPeak Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.